Eiger BioPharmaceuticals (EIGR) Short Interest Ratio & Short Volume Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSustainabilityTrends Eiger BioPharmaceuticals Short Interest DataCurrent Short Interest29,800 sharesPrevious Short Interest33,600 sharesChange Vs. Previous Month-11.31%Dollar Volume Sold Short$149,149.00Short Interest Ratio0.3 Days to CoverLast Record DateMarch 31, 2024Outstanding Shares1,480,000 sharesFloat Size1,310,000 sharesShort Percent of Float2.27%Today's Trading Volume137,800 sharesAverage Trading Volume103,866 sharesToday's Volume Vs. Average133% Short Selling Eiger BioPharmaceuticals ? Sign up to receive the latest short interest report for Eiger BioPharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartEIGR Short Interest Over TimeEIGR Days to Cover Over TimeEIGR Percentage of Float Shorted Over Time Ad DTIWe’re in a code red crisis and 99% of Americans are clueless Folks, it's 2024… Things that we used to rely on - are failing us. Take the phasing out of fossil fuels… Matched with the destruction of oil refineries around the world… And the outright failure of solar and wind technologies… But there is just one solution… And right now governments around the world are stockpiling this resource at the fastest rate in DECADES! And how YOU can prepare for the next 2024 BOOM here! Eiger BioPharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/202429,800 shares $149,149.00 -11.3%2.3%0.3 $5.01 3/15/202433,600 shares $172,704.00 -18.8%2.6%2.8 $5.14 2/29/202441,400 shares $231,840.00 -2.1%3.2%4.2 $5.60 2/15/202442,300 shares $240,264.00 +27.0%3.2%4.7 $5.68 1/31/202433,300 shares $216,783.00 +14.0%2.5%3.8 $6.51 1/15/202429,200 shares $214,912.00 -7.3%2.2%2.8 $7.36 Get the Latest News and Ratings for EIGR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Eiger BioPharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 12/31/202331,500 shares $212,152.50 -97.1%2.1%2.9 $6.74 12/15/20231,070,000 shares $236,363.00 -7.0%N/A3.6 $0.22 11/30/20231,150,000 shares $391,115.00 +13.9%N/A3.5 $0.34 11/15/20231,010,000 shares $358,449.00 -5.6%N/A3.1 $0.35 10/31/20231,070,000 shares $279,270.00 No ChangeN/A3.1 $0.26 10/15/20231,070,000 shares $268,035.00 -7.8%N/A3.3 $0.25 9/30/20231,160,000 shares $353,800.00 -7.2%N/A4 $0.31 9/15/20231,250,000 shares $504,250.00 -0.8%N/A2.8 $0.40 8/31/20231,260,000 shares $1.09 million +4.1%N/A2.9 $0.86 8/15/20231,210,000 shares $738,100.00 +0.8%N/A2.7 $0.61 7/31/20231,200,000 shares $816,000.00 -9.8%N/A2.6 $0.68 7/15/20231,330,000 shares $1.04 million +26.7%N/A2.9 $0.78 6/30/20231,050,000 shares $739,200.00 -55.5%N/A2.1 $0.70 6/15/20232,360,000 shares $2.30 million -4.5%N/A6.2 $0.97 5/31/20232,470,000 shares $2.77 million +1.2%N/A7.4 $1.12 5/15/20232,440,000 shares $3.07 million -3.2%N/A7 $1.26 4/30/20232,520,000 shares $2.60 million -7.0%N/A4.7 $1.03 4/15/20232,710,000 shares $2.95 million +9.3%N/A4.3 $1.09 3/31/20232,480,000 shares $2.22 million +10.7%N/A3.7 $0.90 3/15/20232,240,000 shares $2.64 million +12.6%N/A3 $1.18 2/28/20231,990,000 shares $3.74 million -7.9%N/A1.7 $1.88 2/15/20232,160,000 shares $4.82 million +56.5%N/A1.9 $2.23 1/31/20231,380,000 shares $2.62 million +15.0%N/A1.2 $1.90 1/15/20231,200,000 shares $1.80 million -21.1%N/A1.3 $1.50 12/30/20221,520,000 shares $1.79 million -3.2%N/A1.7 $1.18 12/15/20221,570,000 shares $2.03 million +8.3%N/A2 $1.29 11/30/20221,450,000 shares $6.58 million -13.2%N/A2.5 $4.54 11/15/20221,670,000 shares $7.63 million -8.2%N/A4.9 $4.57 10/31/20221,820,000 shares $9.30 million -3.7%N/A5.3 $5.11 10/15/20221,890,000 shares $11.14 million -2.1%N/A5.7 $5.90 9/30/20221,930,000 shares $14.53 million +13.5%N/A6.3 $7.53 9/15/20221,700,000 shares $12.84 million -0.6%N/A5.4 $7.55 8/31/20221,710,000 shares $14.12 million -10.9%N/A5.3 $8.26 8/15/20221,920,000 shares $18.55 million -6.3%N/A5.9 $9.66How a $0.25 cent option contract makes my top traders feel (Ad)If you don’t know me, I’ve been in the markets for over 40 years… but recently, I’ve discovered a breakthrough that might be my favorite strategy of ALL time! While I kept the finer details of these $0.25 Cent Trades under wraps until recently…Click now to see for yourself what $0.25 Cent Trades is all about 7/31/20222,050,000 shares $17.81 million -1.9%N/A5.3 $8.69 7/15/20222,090,000 shares $17.49 million +10.0%N/A5.3 $8.37 6/30/20221,900,000 shares $11.97 million +13.1%12.0%3.9 $6.30 6/15/20221,680,000 shares $9.02 million -1.2%10.6%2.9 $5.37 5/31/20221,700,000 shares $11.80 million -12.8%N/A1.5 $6.94 5/15/20221,950,000 shares $14.22 million +0.5%N/A1.8 $7.29 4/30/20221,940,000 shares $13.33 million +4.3%6.3%1.9 $6.87 4/15/20221,860,000 shares $13.11 million -15.5%6.1%1.9 $7.05 3/31/20222,200,000 shares $18.26 million +76.0%N/A2.4 $8.30 3/15/20221,250,000 shares $6.81 million +15.7%4.1%1.5 $5.45 2/28/20221,080,000 shares $4.32 million +6.9%3.4%4.5 $4.00 2/15/20221,010,000 shares $4.43 million +9.9%3.2%4.2 $4.39 1/31/2022919,200 shares $3.97 million +24.9%2.9%4.1 $4.32 1/15/2022735,900 shares $3.47 million +13.0%N/A3.2 $4.72 12/31/2021651,100 shares $3.38 million -1.7%2.1%3 $5.19 12/15/2021662,100 shares $3.65 million -8.8%2.1%3.1 $5.51 11/30/2021726,100 shares $4.47 million +9.5%2.3%4.1 $6.15 11/15/2021662,900 shares $5.30 million -2.1%2.1%3.8 $8.00 10/29/2021676,900 shares $4.56 million -10.3%2.2%3.9 $6.74 10/15/2021754,300 shares $4.94 million +10.5%2.5%4.4 $6.55 9/30/2021682,700 shares $4.56 million -8.9%2.3%4 $6.68 9/15/2021749,000 shares $5.45 million -3.5%2.5%3.9 $7.28 8/31/2021775,800 shares $6.32 million -11.4%2.6%4.2 $8.14 8/13/2021875,200 shares $7.66 million -1.3%2.8%4.9 $8.75 7/30/2021886,600 shares $7.06 million +0.8%2.9%4.9 $7.96 7/15/2021879,600 shares $6.98 million +1.6%2.8%4.7 $7.93 6/30/2021865,500 shares $7.37 million -6.3%2.8%4.6 $8.52 6/15/2021923,900 shares $7.49 million +1.3%3.0%5 $8.11 5/28/2021912,100 shares $7.17 million -3.6%3.0%5.1 $7.86 5/14/2021945,800 shares $7.59 million -9.9%N/A4.8 $8.03 4/30/20211,050,000 shares $9.04 million -28.1%N/A4.8 $8.61 4/15/20211,460,000 shares $12.51 million -9.9%N/A0 $8.57 3/31/20211,620,000 shares $14.11 million +5.9%N/A6.6 $8.71 3/15/20211,530,000 shares $15.28 million -1.3%N/A4.8 $9.99 2/26/20211,550,000 shares $16.18 million -1.9%N/A4 $10.44 2/12/20211,580,000 shares $18.66 million -2.5%N/A3.4 $11.81 1/29/20211,620,000 shares $15.96 million +0.6%N/A3.1 $9.85 1/15/20211,610,000 shares $19.09 million +8.8%N/A3 $11.86 12/31/20201,480,000 shares $16.58 million -2.6%N/A2.5 $11.20 12/15/20201,520,000 shares $15.17 million -15.1%N/A2.6 $9.98 11/30/20201,790,000 shares $16.47 million +24.3%N/A3.2 $9.20 11/15/20201,440,000 shares $15.19 million -4.0%N/A2.7 $10.55 10/30/20201,500,000 shares $13.47 million +4.2%N/A3 $8.98 10/15/20201,440,000 shares $12.41 million +4.4%N/A2.9 $8.62 9/30/20201,380,000 shares $11.23 million +13.1%N/A2.8 $8.14 9/15/20201,220,000 shares $12.13 million +0.8%N/A2.8 $9.94 8/31/20201,210,000 shares $13.52 million +2.5%N/A2.9 $11.17 8/14/20201,180,000 shares $13.32 million +43.6%N/A2.8 $11.29 7/31/2020821,500 shares $8.26 million +35.9%N/A2 $10.05 7/15/2020604,500 shares $5.72 million -12.4%2.7%1.5 $9.47How a $0.25 cent option contract makes my top traders feel (Ad)If you don’t know me, I’ve been in the markets for over 40 years… but recently, I’ve discovered a breakthrough that might be my favorite strategy of ALL time! While I kept the finer details of these $0.25 Cent Trades under wraps until recently…Click now to see for yourself what $0.25 Cent Trades is all about 6/30/2020690,000 shares $6.64 million +17.3%3.1%1.9 $9.63 6/15/2020588,100 shares $6.32 million -9.2%2.7%1.6 $10.74 5/29/2020647,600 shares $7.94 million -15.8%2.9%1.7 $12.26 5/15/2020769,500 shares $8.86 million +8.2%3.5%1.9 $11.52 4/30/2020711,400 shares $5.29 million -2.9%3.2%1.9 $7.44 4/15/2020732,800 shares $5.94 million +4.9%3.4%2 $8.10 3/31/2020698,400 shares $5.62 million -27.4%3.2%1.9 $8.05 3/13/2020961,600 shares $7.39 million +14.5%4.5%2.4 $7.68 2/28/2020840,100 shares $4.95 million +97.5%3.9%2.8 $5.89 2/14/2020425,400 shares $3.17 million -15.3%2.0%1.6 $7.46 1/31/2020502,100 shares $5.06 million +20.6%2.3%2.2 $10.07 1/15/2020416,500 shares $4.99 million -12.4%1.9%2.1 $11.99 12/31/2019475,400 shares $6.32 million -8.9%2.2%2.7 $13.30 EIGR Short Interest - Frequently Asked Questions What is Eiger BioPharmaceuticals' current short interest? Short interest is the volume of Eiger BioPharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of March 31st, traders have sold 29,800 shares of EIGR short. 2.27% of Eiger BioPharmaceuticals' shares are currently sold short. Learn More on Eiger BioPharmaceuticals' current short interest. What is a good short interest percentage for Eiger BioPharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.27% of Eiger BioPharmaceuticals' floating shares are currently sold short. Is Eiger BioPharmaceuticals' short interest increasing or decreasing? Eiger BioPharmaceuticals saw a decline in short interest during the month of March. As of March 31st, there was short interest totaling 29,800 shares, a decline of 11.3% from the previous total of 33,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Eiger BioPharmaceuticals' float size? Eiger BioPharmaceuticals currently has issued a total of 1,480,000 shares. Some of Eiger BioPharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Eiger BioPharmaceuticals currently has a public float of 1,310,000 shares. How does Eiger BioPharmaceuticals' short interest compare to its competitors? 2.27% of Eiger BioPharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Eiger BioPharmaceuticals: Cabaletta Bio, Inc. (15.56%), and Voyager Therapeutics, Inc. (7.46%). Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Eiger BioPharmaceuticals stock? Short selling EIGR is an investing strategy that aims to generate trading profit from Eiger BioPharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Eiger BioPharmaceuticals? A short squeeze for Eiger BioPharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of EIGR, which in turn drives the price of the stock up even further. How often is Eiger BioPharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EIGR, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: 180 Life Sciences Short Squeeze Alpha Tau Medical Short Squeeze Apollomics Short Squeeze BriaCell Therapeutics Short Squeeze Cardio Diagnostics Short Squeeze Carmell Short Squeeze Cassava Sciences Short Squeeze Celularity Short Squeeze Clene Short Squeeze Conduit Pharmaceuticals Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:EIGR) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredNEW AI developed by trader who won 1,129% (in 2 days)Earlier this year one legendary trader captured a 1,129% win (in just 2 days) ... LIVE in front of thousands o...Monument Traders Alliance | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock i...Timothy Sykes | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eiger BioPharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Eiger BioPharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.